Benchmark Holdings plc
Benchmark Holdings plc (BHCCF) Stock Competitors & Peer Comparison
See (BHCCF) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BHCCF | $0.37 | -7.72% | 225.1M | -4.57 | -$0.08 | N/A |
| MKKGY | $29.83 | +0.24% | 64.7B | 18.48 | $1.61 | +1.68% |
| MKGAF | $153.14 | +2.29% | 63.3B | 18.08 | $8.05 | +1.72% |
| IPSEY | $46.15 | +0.00% | 61B | 29.02 | $1.59 | +0.86% |
| TKPHF | $37.00 | +0.00% | 58.4B | 80.43 | $0.46 | +3.57% |
| HLNCF | $5.22 | -0.76% | 49.1B | 23.98 | $0.23 | +1.66% |
| SDZNY | $93.80 | +9.78% | 36.7B | 163.67 | $0.52 | +0.85% |
| TEVJF | $28.36 | +0.00% | 32.5B | 23.44 | $1.21 | N/A |
| SGIOF | $25.94 | -0.23% | 22.1B | 20.27 | $1.28 | +1.70% |
| SGIOY | $11.73 | +0.09% | 19.9B | 17.70 | $0.66 | +1.73% |
Stock Comparison
BHCCF vs MKKGY Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, MKKGY has a market cap of 64.7B. Regarding current trading prices, BHCCF is priced at $0.37, while MKKGY trades at $29.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas MKKGY's P/E ratio is 18.48. In terms of profitability, BHCCF's ROE is +0.23%, compared to MKKGY's ROE of +0.10%. Regarding short-term risk, BHCCF is less volatile compared to MKKGY. This indicates potentially lower risk in terms of short-term price fluctuations for BHCCF.Check MKKGY's competition here
BHCCF vs MKGAF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, MKGAF has a market cap of 63.3B. Regarding current trading prices, BHCCF is priced at $0.37, while MKGAF trades at $153.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas MKGAF's P/E ratio is 18.08. In terms of profitability, BHCCF's ROE is +0.23%, compared to MKGAF's ROE of +0.10%. Regarding short-term risk, BHCCF is less volatile compared to MKGAF. This indicates potentially lower risk in terms of short-term price fluctuations for BHCCF.Check MKGAF's competition here
BHCCF vs IPSEY Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, IPSEY has a market cap of 61B. Regarding current trading prices, BHCCF is priced at $0.37, while IPSEY trades at $46.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas IPSEY's P/E ratio is 29.02. In terms of profitability, BHCCF's ROE is +0.23%, compared to IPSEY's ROE of +0.10%. Regarding short-term risk, BHCCF and IPSEY have similar daily volatility (0.00).Check IPSEY's competition here
BHCCF vs TKPHF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, TKPHF has a market cap of 58.4B. Regarding current trading prices, BHCCF is priced at $0.37, while TKPHF trades at $37.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas TKPHF's P/E ratio is 80.43. In terms of profitability, BHCCF's ROE is +0.23%, compared to TKPHF's ROE of +0.02%. Regarding short-term risk, BHCCF and TKPHF have similar daily volatility (0.00).Check TKPHF's competition here
BHCCF vs HLNCF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, HLNCF has a market cap of 49.1B. Regarding current trading prices, BHCCF is priced at $0.37, while HLNCF trades at $5.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas HLNCF's P/E ratio is 23.98. In terms of profitability, BHCCF's ROE is +0.23%, compared to HLNCF's ROE of +0.09%. Regarding short-term risk, BHCCF and HLNCF have similar daily volatility (0.00).Check HLNCF's competition here
BHCCF vs SDZNY Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, SDZNY has a market cap of 36.7B. Regarding current trading prices, BHCCF is priced at $0.37, while SDZNY trades at $93.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas SDZNY's P/E ratio is 163.67. In terms of profitability, BHCCF's ROE is +0.23%, compared to SDZNY's ROE of +0.02%. Regarding short-term risk, BHCCF is less volatile compared to SDZNY. This indicates potentially lower risk in terms of short-term price fluctuations for BHCCF.Check SDZNY's competition here
BHCCF vs TEVJF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, TEVJF has a market cap of 32.5B. Regarding current trading prices, BHCCF is priced at $0.37, while TEVJF trades at $28.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas TEVJF's P/E ratio is 23.44. In terms of profitability, BHCCF's ROE is +0.23%, compared to TEVJF's ROE of +0.20%. Regarding short-term risk, BHCCF and TEVJF have similar daily volatility (0.00).Check TEVJF's competition here
BHCCF vs SGIOF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, SGIOF has a market cap of 22.1B. Regarding current trading prices, BHCCF is priced at $0.37, while SGIOF trades at $25.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas SGIOF's P/E ratio is 20.27. In terms of profitability, BHCCF's ROE is +0.23%, compared to SGIOF's ROE of +0.14%. Regarding short-term risk, BHCCF is less volatile compared to SGIOF. This indicates potentially lower risk in terms of short-term price fluctuations for BHCCF.Check SGIOF's competition here
BHCCF vs SGIOY Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, SGIOY has a market cap of 19.9B. Regarding current trading prices, BHCCF is priced at $0.37, while SGIOY trades at $11.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas SGIOY's P/E ratio is 17.70. In terms of profitability, BHCCF's ROE is +0.23%, compared to SGIOY's ROE of +0.14%. Regarding short-term risk, BHCCF is less volatile compared to SGIOY. This indicates potentially lower risk in terms of short-term price fluctuations for BHCCF.Check SGIOY's competition here
BHCCF vs TAIPY Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, TAIPY has a market cap of 18.1B. Regarding current trading prices, BHCCF is priced at $0.37, while TAIPY trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas TAIPY's P/E ratio is 82.35. In terms of profitability, BHCCF's ROE is +0.23%, compared to TAIPY's ROE of +0.02%. Regarding short-term risk, BHCCF is less volatile compared to TAIPY. This indicates potentially lower risk in terms of short-term price fluctuations for BHCCF.Check TAIPY's competition here
BHCCF vs ESALY Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, BHCCF is priced at $0.37, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas ESALY's P/E ratio is 20.54. In terms of profitability, BHCCF's ROE is +0.23%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, BHCCF is less volatile compared to ESALY. This indicates potentially lower risk in terms of short-term price fluctuations for BHCCF.Check ESALY's competition here
BHCCF vs BIOVF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, BIOVF has a market cap of 12.8B. Regarding current trading prices, BHCCF is priced at $0.37, while BIOVF trades at $37.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas BIOVF's P/E ratio is 246.67. In terms of profitability, BHCCF's ROE is +0.23%, compared to BIOVF's ROE of +0.01%. Regarding short-term risk, BHCCF and BIOVF have similar daily volatility (0.00).Check BIOVF's competition here
BHCCF vs IPSEF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, IPSEF has a market cap of 9.4B. Regarding current trading prices, BHCCF is priced at $0.37, while IPSEF trades at $113.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas IPSEF's P/E ratio is 18.07. In terms of profitability, BHCCF's ROE is +0.23%, compared to IPSEF's ROE of +0.12%. Regarding short-term risk, BHCCF and IPSEF have similar daily volatility (0.00).Check IPSEF's competition here
BHCCF vs ESALF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, ESALF has a market cap of 9.3B. Regarding current trading prices, BHCCF is priced at $0.37, while ESALF trades at $33.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas ESALF's P/E ratio is 28.95. In terms of profitability, BHCCF's ROE is +0.23%, compared to ESALF's ROE of +0.05%. Regarding short-term risk, BHCCF and ESALF have similar daily volatility (0.00).Check ESALF's competition here
BHCCF vs ESAIY Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, ESAIY has a market cap of 9.3B. Regarding current trading prices, BHCCF is priced at $0.37, while ESAIY trades at $8.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas ESAIY's P/E ratio is 29.11. In terms of profitability, BHCCF's ROE is +0.23%, compared to ESAIY's ROE of +0.05%. Regarding short-term risk, BHCCF is less volatile compared to ESAIY. This indicates potentially lower risk in terms of short-term price fluctuations for BHCCF.Check ESAIY's competition here
BHCCF vs SFOSF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, SFOSF has a market cap of 6.9B. Regarding current trading prices, BHCCF is priced at $0.37, while SFOSF trades at $2.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas SFOSF's P/E ratio is 14.50. In terms of profitability, BHCCF's ROE is +0.23%, compared to SFOSF's ROE of +0.07%. Regarding short-term risk, BHCCF and SFOSF have similar daily volatility (0.00).Check SFOSF's competition here
BHCCF vs SMDPY Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, SMDPY has a market cap of 6.1B. Regarding current trading prices, BHCCF is priced at $0.37, while SMDPY trades at $15.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas SMDPY's P/E ratio is 6.02. In terms of profitability, BHCCF's ROE is +0.23%, compared to SMDPY's ROE of +0.49%. Regarding short-term risk, BHCCF and SMDPY have similar daily volatility (0.00).Check SMDPY's competition here
BHCCF vs LVZPF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, LVZPF has a market cap of 6.1B. Regarding current trading prices, BHCCF is priced at $0.37, while LVZPF trades at $5.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas LVZPF's P/E ratio is 15.35. In terms of profitability, BHCCF's ROE is +0.23%, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, BHCCF and LVZPF have similar daily volatility (0.00).Check LVZPF's competition here
BHCCF vs GZPHF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, GZPHF has a market cap of 5.9B. Regarding current trading prices, BHCCF is priced at $0.37, while GZPHF trades at $2.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas GZPHF's P/E ratio is 9.00. In terms of profitability, BHCCF's ROE is +0.23%, compared to GZPHF's ROE of +0.08%. Regarding short-term risk, BHCCF and GZPHF have similar daily volatility (0.00).Check GZPHF's competition here
BHCCF vs DNPUF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, DNPUF has a market cap of 5.9B. Regarding current trading prices, BHCCF is priced at $0.37, while DNPUF trades at $14.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas DNPUF's P/E ratio is 5.81. In terms of profitability, BHCCF's ROE is +0.23%, compared to DNPUF's ROE of +0.49%. Regarding short-term risk, BHCCF is less volatile compared to DNPUF. This indicates potentially lower risk in terms of short-term price fluctuations for BHCCF.Check DNPUF's competition here
BHCCF vs HLUBF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, HLUBF has a market cap of 5.8B. Regarding current trading prices, BHCCF is priced at $0.37, while HLUBF trades at $5.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas HLUBF's P/E ratio is 11.43. In terms of profitability, BHCCF's ROE is +0.23%, compared to HLUBF's ROE of +0.13%. Regarding short-term risk, BHCCF and HLUBF have similar daily volatility (0.00).Check HLUBF's competition here
BHCCF vs HLBBF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, HLBBF has a market cap of 4.9B. Regarding current trading prices, BHCCF is priced at $0.37, while HLBBF trades at $6.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas HLBBF's P/E ratio is 12.17. In terms of profitability, BHCCF's ROE is +0.23%, compared to HLBBF's ROE of +0.13%. Regarding short-term risk, BHCCF and HLBBF have similar daily volatility (0.00).Check HLBBF's competition here
BHCCF vs HKMPF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, HKMPF has a market cap of 4.8B. Regarding current trading prices, BHCCF is priced at $0.37, while HKMPF trades at $21.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas HKMPF's P/E ratio is 13.14. In terms of profitability, BHCCF's ROE is +0.23%, compared to HKMPF's ROE of +0.15%. Regarding short-term risk, BHCCF and HKMPF have similar daily volatility (0.00).Check HKMPF's competition here
BHCCF vs HKMPY Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, HKMPY has a market cap of 4.8B. Regarding current trading prices, BHCCF is priced at $0.37, while HKMPY trades at $44.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas HKMPY's P/E ratio is 13.10. In terms of profitability, BHCCF's ROE is +0.23%, compared to HKMPY's ROE of +0.15%. Regarding short-term risk, BHCCF is less volatile compared to HKMPY. This indicates potentially lower risk in terms of short-term price fluctuations for BHCCF.Check HKMPY's competition here
BHCCF vs SGFEF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, SGFEF has a market cap of 4.6B. Regarding current trading prices, BHCCF is priced at $0.37, while SGFEF trades at $104.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas SGFEF's P/E ratio is 23.51. In terms of profitability, BHCCF's ROE is +0.23%, compared to SGFEF's ROE of +0.16%. Regarding short-term risk, BHCCF and SGFEF have similar daily volatility (0.00).Check SGFEF's competition here
BHCCF vs APNHF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, APNHF has a market cap of 3.6B. Regarding current trading prices, BHCCF is priced at $0.37, while APNHF trades at $8.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas APNHF's P/E ratio is -54.67. In terms of profitability, BHCCF's ROE is +0.23%, compared to APNHF's ROE of -0.01%. Regarding short-term risk, BHCCF and APNHF have similar daily volatility (0.00).Check APNHF's competition here
BHCCF vs APNHY Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, APNHY has a market cap of 3.6B. Regarding current trading prices, BHCCF is priced at $0.37, while APNHY trades at $8.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas APNHY's P/E ratio is -53.67. In terms of profitability, BHCCF's ROE is +0.23%, compared to APNHY's ROE of -0.01%. Regarding short-term risk, BHCCF and APNHY have similar daily volatility (0.00).Check APNHY's competition here
BHCCF vs LBTSF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, LBTSF has a market cap of 3.3B. Regarding current trading prices, BHCCF is priced at $0.37, while LBTSF trades at $15.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas LBTSF's P/E ratio is 66.74. In terms of profitability, BHCCF's ROE is +0.23%, compared to LBTSF's ROE of +0.04%. Regarding short-term risk, BHCCF and LBTSF have similar daily volatility (0.00).Check LBTSF's competition here
BHCCF vs CHSYF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, CHSYF has a market cap of 3.3B. Regarding current trading prices, BHCCF is priced at $0.37, while CHSYF trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas CHSYF's P/E ratio is 13.50. In terms of profitability, BHCCF's ROE is +0.23%, compared to CHSYF's ROE of +0.10%. Regarding short-term risk, BHCCF and CHSYF have similar daily volatility (0.00).Check CHSYF's competition here
BHCCF vs ULIHF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, ULIHF has a market cap of 3.2B. Regarding current trading prices, BHCCF is priced at $0.37, while ULIHF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas ULIHF's P/E ratio is 6.67. In terms of profitability, BHCCF's ROE is +0.23%, compared to ULIHF's ROE of +0.20%. Regarding short-term risk, BHCCF and ULIHF have similar daily volatility (0.00).Check ULIHF's competition here
BHCCF vs INVVY Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, BHCCF is priced at $0.37, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas INVVY's P/E ratio is -62.42. In terms of profitability, BHCCF's ROE is +0.23%, compared to INVVY's ROE of -0.60%. Regarding short-term risk, BHCCF and INVVY have similar daily volatility (0.00).Check INVVY's competition here
BHCCF vs IZQVF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, BHCCF is priced at $0.37, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, BHCCF's ROE is +0.23%, compared to IZQVF's ROE of -0.60%. Regarding short-term risk, BHCCF and IZQVF have similar daily volatility (0.00).Check IZQVF's competition here
BHCCF vs HYPMY Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, HYPMY has a market cap of 2.8B. Regarding current trading prices, BHCCF is priced at $0.37, while HYPMY trades at $4.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas HYPMY's P/E ratio is 17.52. In terms of profitability, BHCCF's ROE is +0.23%, compared to HYPMY's ROE of +0.07%. Regarding short-term risk, BHCCF is less volatile compared to HYPMY. This indicates potentially lower risk in terms of short-term price fluctuations for BHCCF.Check HYPMY's competition here
BHCCF vs HMDCF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, HMDCF has a market cap of 2.6B. Regarding current trading prices, BHCCF is priced at $0.37, while HMDCF trades at $3.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas HMDCF's P/E ratio is 5.70. In terms of profitability, BHCCF's ROE is +0.23%, compared to HMDCF's ROE of +0.47%. Regarding short-term risk, BHCCF and HMDCF have similar daily volatility (0.00).Check HMDCF's competition here
BHCCF vs NPPNY Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, NPPNY has a market cap of 2.3B. Regarding current trading prices, BHCCF is priced at $0.37, while NPPNY trades at $8.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas NPPNY's P/E ratio is 10.92. In terms of profitability, BHCCF's ROE is +0.23%, compared to NPPNY's ROE of +0.12%. Regarding short-term risk, BHCCF and NPPNY have similar daily volatility (0.00).Check NPPNY's competition here
BHCCF vs DMPHF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, DMPHF has a market cap of 2.1B. Regarding current trading prices, BHCCF is priced at $0.37, while DMPHF trades at $39.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas DMPHF's P/E ratio is 17.90. In terms of profitability, BHCCF's ROE is +0.23%, compared to DMPHF's ROE of +0.19%. Regarding short-term risk, BHCCF and DMPHF have similar daily volatility (0.00).Check DMPHF's competition here
BHCCF vs NPNKF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, NPNKF has a market cap of 2.1B. Regarding current trading prices, BHCCF is priced at $0.37, while NPNKF trades at $30.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas NPNKF's P/E ratio is 9.94. In terms of profitability, BHCCF's ROE is +0.23%, compared to NPNKF's ROE of +0.11%. Regarding short-term risk, BHCCF and NPNKF have similar daily volatility (0.00).Check NPNKF's competition here
BHCCF vs HTSUF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, HTSUF has a market cap of 2B. Regarding current trading prices, BHCCF is priced at $0.37, while HTSUF trades at $29.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas HTSUF's P/E ratio is 16.76. In terms of profitability, BHCCF's ROE is +0.23%, compared to HTSUF's ROE of +0.07%. Regarding short-term risk, BHCCF and HTSUF have similar daily volatility (0.00).Check HTSUF's competition here
BHCCF vs ARSUF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, ARSUF has a market cap of 2B. Regarding current trading prices, BHCCF is priced at $0.37, while ARSUF trades at $27.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas ARSUF's P/E ratio is 19.42. In terms of profitability, BHCCF's ROE is +0.23%, compared to ARSUF's ROE of +0.17%. Regarding short-term risk, BHCCF and ARSUF have similar daily volatility (0.00).Check ARSUF's competition here
BHCCF vs DUTV Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, DUTV has a market cap of 1.9B. Regarding current trading prices, BHCCF is priced at $0.37, while DUTV trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas DUTV's P/E ratio is N/A. In terms of profitability, BHCCF's ROE is +0.23%, compared to DUTV's ROE of -0.05%. Regarding short-term risk, BHCCF is less volatile compared to DUTV. This indicates potentially lower risk in terms of short-term price fluctuations for BHCCF.Check DUTV's competition here
BHCCF vs CURLF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, CURLF has a market cap of 1.9B. Regarding current trading prices, BHCCF is priced at $0.37, while CURLF trades at $2.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas CURLF's P/E ratio is -6.86. In terms of profitability, BHCCF's ROE is +0.23%, compared to CURLF's ROE of -0.31%. Regarding short-term risk, BHCCF is less volatile compared to CURLF. This indicates potentially lower risk in terms of short-term price fluctuations for BHCCF.Check CURLF's competition here
BHCCF vs TSMRF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, TSMRF has a market cap of 1.7B. Regarding current trading prices, BHCCF is priced at $0.37, while TSMRF trades at $23.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas TSMRF's P/E ratio is 10.04. In terms of profitability, BHCCF's ROE is +0.23%, compared to TSMRF's ROE of +0.10%. Regarding short-term risk, BHCCF and TSMRF have similar daily volatility (0.00).Check TSMRF's competition here
BHCCF vs MITPF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, BHCCF is priced at $0.37, while MITPF trades at $23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas MITPF's P/E ratio is -10.81. In terms of profitability, BHCCF's ROE is +0.23%, compared to MITPF's ROE of +4.99%. Regarding short-term risk, BHCCF is less volatile compared to MITPF. This indicates potentially lower risk in terms of short-term price fluctuations for BHCCF.Check MITPF's competition here
BHCCF vs SHPHF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, SHPHF has a market cap of 1.6B. Regarding current trading prices, BHCCF is priced at $0.37, while SHPHF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas SHPHF's P/E ratio is -5.67. In terms of profitability, BHCCF's ROE is +0.23%, compared to SHPHF's ROE of -0.02%. Regarding short-term risk, BHCCF and SHPHF have similar daily volatility (0.00).Check SHPHF's competition here
BHCCF vs GTBIF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, GTBIF has a market cap of 1.6B. Regarding current trading prices, BHCCF is priced at $0.37, while GTBIF trades at $6.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas GTBIF's P/E ratio is 39.35. In terms of profitability, BHCCF's ROE is +0.23%, compared to GTBIF's ROE of +0.02%. Regarding short-term risk, BHCCF is less volatile compared to GTBIF. This indicates potentially lower risk in terms of short-term price fluctuations for BHCCF.Check GTBIF's competition here
BHCCF vs KARBF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, BHCCF is priced at $0.37, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas KARBF's P/E ratio is 262.50. In terms of profitability, BHCCF's ROE is +0.23%, compared to KARBF's ROE of N/A. Regarding short-term risk, BHCCF and KARBF have similar daily volatility (0.00).Check KARBF's competition here
BHCCF vs EVOTF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, EVOTF has a market cap of 1.4B. Regarding current trading prices, BHCCF is priced at $0.37, while EVOTF trades at $8.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas EVOTF's P/E ratio is -7.42. In terms of profitability, BHCCF's ROE is +0.23%, compared to EVOTF's ROE of -0.18%. Regarding short-term risk, BHCCF and EVOTF have similar daily volatility (0.00).Check EVOTF's competition here
BHCCF vs CHIZF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, CHIZF has a market cap of 1.4B. Regarding current trading prices, BHCCF is priced at $0.37, while CHIZF trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas CHIZF's P/E ratio is -27.34. In terms of profitability, BHCCF's ROE is +0.23%, compared to CHIZF's ROE of -0.01%. Regarding short-term risk, BHCCF and CHIZF have similar daily volatility (0.00).Check CHIZF's competition here
BHCCF vs SWGHF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, SWGHF has a market cap of 1.3B. Regarding current trading prices, BHCCF is priced at $0.37, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas SWGHF's P/E ratio is 15.57. In terms of profitability, BHCCF's ROE is +0.23%, compared to SWGHF's ROE of +0.05%. Regarding short-term risk, BHCCF and SWGHF have similar daily volatility (0.00).Check SWGHF's competition here
BHCCF vs CASBF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, CASBF has a market cap of 1.3B. Regarding current trading prices, BHCCF is priced at $0.37, while CASBF trades at $3.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas CASBF's P/E ratio is -37.50. In terms of profitability, BHCCF's ROE is +0.23%, compared to CASBF's ROE of -0.03%. Regarding short-term risk, BHCCF and CASBF have similar daily volatility (0.00).Check CASBF's competition here
BHCCF vs TCNNF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, TCNNF has a market cap of 1.2B. Regarding current trading prices, BHCCF is priced at $0.37, while TCNNF trades at $6.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas TCNNF's P/E ratio is -10.32. In terms of profitability, BHCCF's ROE is +0.23%, compared to TCNNF's ROE of -0.11%. Regarding short-term risk, BHCCF is less volatile compared to TCNNF. This indicates potentially lower risk in terms of short-term price fluctuations for BHCCF.Check TCNNF's competition here
BHCCF vs LJUIF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, LJUIF has a market cap of 1.2B. Regarding current trading prices, BHCCF is priced at $0.37, while LJUIF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas LJUIF's P/E ratio is 13.42. In terms of profitability, BHCCF's ROE is +0.23%, compared to LJUIF's ROE of +0.09%. Regarding short-term risk, BHCCF and LJUIF have similar daily volatility (0.00).Check LJUIF's competition here
BHCCF vs KSPHF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, KSPHF has a market cap of 1.1B. Regarding current trading prices, BHCCF is priced at $0.37, while KSPHF trades at $26.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas KSPHF's P/E ratio is 12.04. In terms of profitability, BHCCF's ROE is +0.23%, compared to KSPHF's ROE of +0.07%. Regarding short-term risk, BHCCF and KSPHF have similar daily volatility (0.00).Check KSPHF's competition here
BHCCF vs BIOGY Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, BIOGY has a market cap of 1.1B. Regarding current trading prices, BHCCF is priced at $0.37, while BIOGY trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas BIOGY's P/E ratio is 31.43. In terms of profitability, BHCCF's ROE is +0.23%, compared to BIOGY's ROE of +0.24%. Regarding short-term risk, BHCCF and BIOGY have similar daily volatility (0.00).Check BIOGY's competition here
BHCCF vs GNMLF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, GNMLF has a market cap of 1B. Regarding current trading prices, BHCCF is priced at $0.37, while GNMLF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas GNMLF's P/E ratio is 10.00. In terms of profitability, BHCCF's ROE is +0.23%, compared to GNMLF's ROE of +0.13%. Regarding short-term risk, BHCCF and GNMLF have similar daily volatility (0.00).Check GNMLF's competition here
BHCCF vs KKPCF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, KKPCF has a market cap of 984.6M. Regarding current trading prices, BHCCF is priced at $0.37, while KKPCF trades at $26.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas KKPCF's P/E ratio is 288.89. In terms of profitability, BHCCF's ROE is +0.23%, compared to KKPCF's ROE of -0.03%. Regarding short-term risk, BHCCF and KKPCF have similar daily volatility (0.00).Check KKPCF's competition here
BHCCF vs TWAPF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, TWAPF has a market cap of 828.5M. Regarding current trading prices, BHCCF is priced at $0.37, while TWAPF trades at $16.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas TWAPF's P/E ratio is 6.28. In terms of profitability, BHCCF's ROE is +0.23%, compared to TWAPF's ROE of +0.12%. Regarding short-term risk, BHCCF and TWAPF have similar daily volatility (0.00).Check TWAPF's competition here
BHCCF vs NIKA Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, NIKA has a market cap of 785.6M. Regarding current trading prices, BHCCF is priced at $0.37, while NIKA trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas NIKA's P/E ratio is N/A. In terms of profitability, BHCCF's ROE is +0.23%, compared to NIKA's ROE of +0.21%. Regarding short-term risk, BHCCF and NIKA have similar daily volatility (0.00).Check NIKA's competition here
BHCCF vs CSWYF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, CSWYF has a market cap of 758.4M. Regarding current trading prices, BHCCF is priced at $0.37, while CSWYF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas CSWYF's P/E ratio is 4.78. In terms of profitability, BHCCF's ROE is +0.23%, compared to CSWYF's ROE of +0.20%. Regarding short-term risk, BHCCF and CSWYF have similar daily volatility (0.00).Check CSWYF's competition here
BHCCF vs TRXPF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, TRXPF has a market cap of 690.7M. Regarding current trading prices, BHCCF is priced at $0.37, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, BHCCF's ROE is +0.23%, compared to TRXPF's ROE of +0.04%. Regarding short-term risk, BHCCF and TRXPF have similar daily volatility (0.00).Check TRXPF's competition here
BHCCF vs SHEZF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, SHEZF has a market cap of 690.3M. Regarding current trading prices, BHCCF is priced at $0.37, while SHEZF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas SHEZF's P/E ratio is -23.48. In terms of profitability, BHCCF's ROE is +0.23%, compared to SHEZF's ROE of +0.03%. Regarding short-term risk, BHCCF and SHEZF have similar daily volatility (0.00).Check SHEZF's competition here
BHCCF vs YIHCF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, YIHCF has a market cap of 643.1M. Regarding current trading prices, BHCCF is priced at $0.37, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, BHCCF's ROE is +0.23%, compared to YIHCF's ROE of +0.06%. Regarding short-term risk, BHCCF and YIHCF have similar daily volatility (0.00).Check YIHCF's competition here
BHCCF vs GLASF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, GLASF has a market cap of 630.7M. Regarding current trading prices, BHCCF is priced at $0.37, while GLASF trades at $8.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas GLASF's P/E ratio is -38.86. In terms of profitability, BHCCF's ROE is +0.23%, compared to GLASF's ROE of -0.01%. Regarding short-term risk, BHCCF is less volatile compared to GLASF. This indicates potentially lower risk in terms of short-term price fluctuations for BHCCF.Check GLASF's competition here
BHCCF vs AIHLF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, AIHLF has a market cap of 624.3M. Regarding current trading prices, BHCCF is priced at $0.37, while AIHLF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas AIHLF's P/E ratio is 10.94. In terms of profitability, BHCCF's ROE is +0.23%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, BHCCF and AIHLF have similar daily volatility (0.00).Check AIHLF's competition here
BHCCF vs TRSSF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, BHCCF is priced at $0.37, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, BHCCF's ROE is +0.23%, compared to TRSSF's ROE of -0.85%. Regarding short-term risk, BHCCF is less volatile compared to TRSSF. This indicates potentially lower risk in terms of short-term price fluctuations for BHCCF.Check TRSSF's competition here
BHCCF vs PKBFF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, PKBFF has a market cap of 544.7M. Regarding current trading prices, BHCCF is priced at $0.37, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas PKBFF's P/E ratio is N/A. In terms of profitability, BHCCF's ROE is +0.23%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, BHCCF and PKBFF have similar daily volatility (0.00).Check PKBFF's competition here
BHCCF vs CCHWF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, BHCCF is priced at $0.37, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, BHCCF's ROE is +0.23%, compared to CCHWF's ROE of +0.42%. Regarding short-term risk, BHCCF is less volatile compared to CCHWF. This indicates potentially lower risk in terms of short-term price fluctuations for BHCCF.Check CCHWF's competition here
BHCCF vs BOIRF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, BOIRF has a market cap of 520.9M. Regarding current trading prices, BHCCF is priced at $0.37, while BOIRF trades at $30.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas BOIRF's P/E ratio is 22.73. In terms of profitability, BHCCF's ROE is +0.23%, compared to BOIRF's ROE of +0.05%. Regarding short-term risk, BHCCF and BOIRF have similar daily volatility (0.00).Check BOIRF's competition here
BHCCF vs AGYTF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, AGYTF has a market cap of 504.6M. Regarding current trading prices, BHCCF is priced at $0.37, while AGYTF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas AGYTF's P/E ratio is -11.00. In terms of profitability, BHCCF's ROE is +0.23%, compared to AGYTF's ROE of +1.75%. Regarding short-term risk, BHCCF and AGYTF have similar daily volatility (0.00).Check AGYTF's competition here
BHCCF vs KHTRF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, KHTRF has a market cap of 474.3M. Regarding current trading prices, BHCCF is priced at $0.37, while KHTRF trades at $4.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas KHTRF's P/E ratio is -157.43. In terms of profitability, BHCCF's ROE is +0.23%, compared to KHTRF's ROE of -0.00%. Regarding short-term risk, BHCCF and KHTRF have similar daily volatility (0.00).Check KHTRF's competition here
BHCCF vs PEXXF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, BHCCF is priced at $0.37, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, BHCCF's ROE is +0.23%, compared to PEXXF's ROE of N/A. Regarding short-term risk, BHCCF and PEXXF have similar daily volatility (0.00).Check PEXXF's competition here
BHCCF vs SWDCF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, SWDCF has a market cap of 443.7M. Regarding current trading prices, BHCCF is priced at $0.37, while SWDCF trades at $2.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas SWDCF's P/E ratio is 69.40. In terms of profitability, BHCCF's ROE is +0.23%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, BHCCF and SWDCF have similar daily volatility (0.00).Check SWDCF's competition here
BHCCF vs ELTP Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, ELTP has a market cap of 426M. Regarding current trading prices, BHCCF is priced at $0.37, while ELTP trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas ELTP's P/E ratio is 19.83. In terms of profitability, BHCCF's ROE is +0.23%, compared to ELTP's ROE of +0.71%. Regarding short-term risk, BHCCF is less volatile compared to ELTP. This indicates potentially lower risk in terms of short-term price fluctuations for BHCCF.Check ELTP's competition here
BHCCF vs HUMDF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, HUMDF has a market cap of 405.4M. Regarding current trading prices, BHCCF is priced at $0.37, while HUMDF trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas HUMDF's P/E ratio is 2.74. In terms of profitability, BHCCF's ROE is +0.23%, compared to HUMDF's ROE of +2.33%. Regarding short-term risk, BHCCF and HUMDF have similar daily volatility (0.00).Check HUMDF's competition here
BHCCF vs VRNOF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, VRNOF has a market cap of 358.2M. Regarding current trading prices, BHCCF is priced at $0.37, while VRNOF trades at $0.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas VRNOF's P/E ratio is -1.00. In terms of profitability, BHCCF's ROE is +0.23%, compared to VRNOF's ROE of -0.52%. Regarding short-term risk, BHCCF is less volatile compared to VRNOF. This indicates potentially lower risk in terms of short-term price fluctuations for BHCCF.Check VRNOF's competition here
BHCCF vs CRLBF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, CRLBF has a market cap of 346.1M. Regarding current trading prices, BHCCF is priced at $0.37, while CRLBF trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas CRLBF's P/E ratio is -6.35. In terms of profitability, BHCCF's ROE is +0.23%, compared to CRLBF's ROE of -0.12%. Regarding short-term risk, BHCCF is less volatile compared to CRLBF. This indicates potentially lower risk in terms of short-term price fluctuations for BHCCF.Check CRLBF's competition here
BHCCF vs CPHRF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, CPHRF has a market cap of 285M. Regarding current trading prices, BHCCF is priced at $0.37, while CPHRF trades at $11.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas CPHRF's P/E ratio is 16.77. In terms of profitability, BHCCF's ROE is +0.23%, compared to CPHRF's ROE of +0.16%. Regarding short-term risk, BHCCF is less volatile compared to CPHRF. This indicates potentially lower risk in terms of short-term price fluctuations for BHCCF.Check CPHRF's competition here
BHCCF vs PLNHF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, BHCCF is priced at $0.37, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, BHCCF's ROE is +0.23%, compared to PLNHF's ROE of -0.94%. Regarding short-term risk, BHCCF is less volatile compared to PLNHF. This indicates potentially lower risk in terms of short-term price fluctuations for BHCCF.Check PLNHF's competition here
BHCCF vs PHCUF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, PHCUF has a market cap of 186.2M. Regarding current trading prices, BHCCF is priced at $0.37, while PHCUF trades at $7.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas PHCUF's P/E ratio is 700.00. In terms of profitability, BHCCF's ROE is +0.23%, compared to PHCUF's ROE of -0.00%. Regarding short-term risk, BHCCF and PHCUF have similar daily volatility (0.00).Check PHCUF's competition here
BHCCF vs SHIEF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, SHIEF has a market cap of 150.9M. Regarding current trading prices, BHCCF is priced at $0.37, while SHIEF trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas SHIEF's P/E ratio is -7.06. In terms of profitability, BHCCF's ROE is +0.23%, compared to SHIEF's ROE of +1.40%. Regarding short-term risk, BHCCF and SHIEF have similar daily volatility (0.00).Check SHIEF's competition here
BHCCF vs COPHF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, COPHF has a market cap of 131.7M. Regarding current trading prices, BHCCF is priced at $0.37, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas COPHF's P/E ratio is -0.02. In terms of profitability, BHCCF's ROE is +0.23%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, BHCCF is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for BHCCF.Check COPHF's competition here
BHCCF vs BIOYF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, BIOYF has a market cap of 127.7M. Regarding current trading prices, BHCCF is priced at $0.37, while BIOYF trades at $11.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas BIOYF's P/E ratio is 20.62. In terms of profitability, BHCCF's ROE is +0.23%, compared to BIOYF's ROE of +0.23%. Regarding short-term risk, BHCCF is less volatile compared to BIOYF. This indicates potentially lower risk in terms of short-term price fluctuations for BHCCF.Check BIOYF's competition here
BHCCF vs LOVFF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, LOVFF has a market cap of 124.1M. Regarding current trading prices, BHCCF is priced at $0.37, while LOVFF trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas LOVFF's P/E ratio is 14.40. In terms of profitability, BHCCF's ROE is +0.23%, compared to LOVFF's ROE of +0.12%. Regarding short-term risk, BHCCF and LOVFF have similar daily volatility (0.00).Check LOVFF's competition here
BHCCF vs NWPN Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, NWPN has a market cap of 123.7M. Regarding current trading prices, BHCCF is priced at $0.37, while NWPN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas NWPN's P/E ratio is -0.04. In terms of profitability, BHCCF's ROE is +0.23%, compared to NWPN's ROE of +0.13%. Regarding short-term risk, BHCCF is less volatile compared to NWPN. This indicates potentially lower risk in terms of short-term price fluctuations for BHCCF.Check NWPN's competition here
BHCCF vs CBWTF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, CBWTF has a market cap of 121.4M. Regarding current trading prices, BHCCF is priced at $0.37, while CBWTF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas CBWTF's P/E ratio is 3.00. In terms of profitability, BHCCF's ROE is +0.23%, compared to CBWTF's ROE of +0.29%. Regarding short-term risk, BHCCF is less volatile compared to CBWTF. This indicates potentially lower risk in terms of short-term price fluctuations for BHCCF.Check CBWTF's competition here
BHCCF vs LPCUF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, LPCUF has a market cap of 112.1M. Regarding current trading prices, BHCCF is priced at $0.37, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas LPCUF's P/E ratio is 9.51. In terms of profitability, BHCCF's ROE is +0.23%, compared to LPCUF's ROE of +0.04%. Regarding short-term risk, BHCCF and LPCUF have similar daily volatility (0.00).Check LPCUF's competition here
BHCCF vs AAWH Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, AAWH has a market cap of 111.7M. Regarding current trading prices, BHCCF is priced at $0.37, while AAWH trades at $0.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas AAWH's P/E ratio is -1.31. In terms of profitability, BHCCF's ROE is +0.23%, compared to AAWH's ROE of -2.27%. Regarding short-term risk, BHCCF is less volatile compared to AAWH. This indicates potentially lower risk in terms of short-term price fluctuations for BHCCF.Check AAWH's competition here
BHCCF vs CWBHF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, CWBHF has a market cap of 111.6M. Regarding current trading prices, BHCCF is priced at $0.37, while CWBHF trades at $0.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas CWBHF's P/E ratio is -5.00. In terms of profitability, BHCCF's ROE is +0.23%, compared to CWBHF's ROE of -1.20%. Regarding short-term risk, BHCCF is less volatile compared to CWBHF. This indicates potentially lower risk in terms of short-term price fluctuations for BHCCF.Check CWBHF's competition here
BHCCF vs ORXOF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, ORXOF has a market cap of 111.5M. Regarding current trading prices, BHCCF is priced at $0.37, while ORXOF trades at $3.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas ORXOF's P/E ratio is -2.48. In terms of profitability, BHCCF's ROE is +0.23%, compared to ORXOF's ROE of +5.65%. Regarding short-term risk, BHCCF and ORXOF have similar daily volatility (0.00).Check ORXOF's competition here
BHCCF vs CNVCF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, CNVCF has a market cap of 109.2M. Regarding current trading prices, BHCCF is priced at $0.37, while CNVCF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, BHCCF's ROE is +0.23%, compared to CNVCF's ROE of +1.21%. Regarding short-term risk, BHCCF and CNVCF have similar daily volatility (0.00).Check CNVCF's competition here
BHCCF vs HLTRF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, HLTRF has a market cap of 105.1M. Regarding current trading prices, BHCCF is priced at $0.37, while HLTRF trades at $3.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas HLTRF's P/E ratio is -7.47. In terms of profitability, BHCCF's ROE is +0.23%, compared to HLTRF's ROE of -0.21%. Regarding short-term risk, BHCCF and HLTRF have similar daily volatility (0.00).Check HLTRF's competition here
BHCCF vs JUSHF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, JUSHF has a market cap of 103.8M. Regarding current trading prices, BHCCF is priced at $0.37, while JUSHF trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas JUSHF's P/E ratio is -1.60. In terms of profitability, BHCCF's ROE is +0.23%, compared to JUSHF's ROE of +0.89%. Regarding short-term risk, BHCCF is less volatile compared to JUSHF. This indicates potentially lower risk in terms of short-term price fluctuations for BHCCF.Check JUSHF's competition here
BHCCF vs ORXOY Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, ORXOY has a market cap of 102.7M. Regarding current trading prices, BHCCF is priced at $0.37, while ORXOY trades at $2.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas ORXOY's P/E ratio is -2.28. In terms of profitability, BHCCF's ROE is +0.23%, compared to ORXOY's ROE of +5.65%. Regarding short-term risk, BHCCF and ORXOY have similar daily volatility (0.00).Check ORXOY's competition here
BHCCF vs ABSCF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, ABSCF has a market cap of 96M. Regarding current trading prices, BHCCF is priced at $0.37, while ABSCF trades at $1.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas ABSCF's P/E ratio is -8.06. In terms of profitability, BHCCF's ROE is +0.23%, compared to ABSCF's ROE of +0.33%. Regarding short-term risk, BHCCF and ABSCF have similar daily volatility (0.00).Check ABSCF's competition here
BHCCF vs GRUSF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, GRUSF has a market cap of 93.2M. Regarding current trading prices, BHCCF is priced at $0.37, while GRUSF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas GRUSF's P/E ratio is 12.44. In terms of profitability, BHCCF's ROE is +0.23%, compared to GRUSF's ROE of +0.28%. Regarding short-term risk, BHCCF is less volatile compared to GRUSF. This indicates potentially lower risk in terms of short-term price fluctuations for BHCCF.Check GRUSF's competition here
BHCCF vs EOFBY Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, EOFBY has a market cap of 73.7M. Regarding current trading prices, BHCCF is priced at $0.37, while EOFBY trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas EOFBY's P/E ratio is -7.67. In terms of profitability, BHCCF's ROE is +0.23%, compared to EOFBY's ROE of -0.77%. Regarding short-term risk, BHCCF and EOFBY have similar daily volatility (0.00).Check EOFBY's competition here
BHCCF vs MEDXF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, MEDXF has a market cap of 66.8M. Regarding current trading prices, BHCCF is priced at $0.37, while MEDXF trades at $2.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas MEDXF's P/E ratio is -103.00. In terms of profitability, BHCCF's ROE is +0.23%, compared to MEDXF's ROE of -0.01%. Regarding short-term risk, BHCCF is less volatile compared to MEDXF. This indicates potentially lower risk in terms of short-term price fluctuations for BHCCF.Check MEDXF's competition here
BHCCF vs GDNSF Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, GDNSF has a market cap of 61M. Regarding current trading prices, BHCCF is priced at $0.37, while GDNSF trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas GDNSF's P/E ratio is -2.66. In terms of profitability, BHCCF's ROE is +0.23%, compared to GDNSF's ROE of -0.24%. Regarding short-term risk, BHCCF and GDNSF have similar daily volatility (0.00).Check GDNSF's competition here
BHCCF vs PLNH Comparison February 2026
BHCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BHCCF stands at 225.1M. In comparison, PLNH has a market cap of 56.6M. Regarding current trading prices, BHCCF is priced at $0.37, while PLNH trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BHCCF currently has a P/E ratio of -4.57, whereas PLNH's P/E ratio is -0.67. In terms of profitability, BHCCF's ROE is +0.23%, compared to PLNH's ROE of -0.91%. Regarding short-term risk, BHCCF is less volatile compared to PLNH. This indicates potentially lower risk in terms of short-term price fluctuations for BHCCF.Check PLNH's competition here